KRAS-Mutant NSCLC Exhibits Different Genetic, Molecular Characteristics Across Racial Groups
Researchers found that molecular profiles of patients with KRAS-mutant NSCLC differ among patients from various racial groups.
Researchers found that molecular profiles of patients with KRAS-mutant NSCLC differ among patients from various racial groups.
Black women with cervical cancer were less likely to receive brachytherapy and had poorer survival, suggesting brachytherapy may mediate survival outcomes.
The presence of CHEK2 or PALB2 variants in Hispanic women is enough to warrant the addition of an annual breast MRI, said study authors.
Among black women in the United States, the prevalence of triple-negative breast cancer varies by birthplace.
A retrospective analysis revealed that opening up access to health care eliminated the gap in timeliness to care between white and black patients.
Differences in care were most prominent when centers with a high proportion of minority patients were compared with the quality outcomes of white patients.
Racial minorities are poorly represented in genomic research databases, raising important questions about whether or not all patients will benefit equally from advances in precision oncology.
African Americans have a 60% higher incidence of prostate cancer and are about 2 times more likely to die from the disease.
Patient outcomes following the diagnosis of multiple myeloma have improved markedly over recent years, but racial and ethnic disparities exist.
In this question-and-answer session, Cancer Therapy Advisor asked Dr Duma about her team’s study and minority patient representation in breast cancer studies.